Efficacy and Safety of the Minimed 780G® Advanced Hybrid Closed Loop System (AHCL) in Patients With Type 1 Diabetes Undergoing Surgery

CompletedOBSERVATIONAL
Enrollment

15

Participants

Timeline

Start Date

August 1, 2023

Primary Completion Date

January 31, 2025

Study Completion Date

April 30, 2025

Conditions
Type 1 Diabetes (T1D)Surgery, Day
Interventions
DEVICE

AHCL

The downloaded data will be analyzed prior to the surgical procedure. In accordance with standard clinical practice, a TBR time-under-range % (\<54 mg/dL) or TBR time-under-range % (\<70 mg/dL) greater than 4% will be identified, and the target glucose will be increased by 10 mg/dL relative to the previously established value. This is intended to reduce the risk of perioperative hypoglycemia.

Trial Locations (1)

860.015.536-1

Hospital Universitario San Ignacio, Bogota

All Listed Sponsors
collaborator

Pontificia Universidad Javeriana

OTHER

lead

Hospital Universitario San Ignacio

OTHER